Relay Therapeutics, Inc. RLAY Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s other accrued liabilities?
- Relay Therapeutics, Inc. (RLAY) reported other accrued liabilities of $847K in Q1 2026.
- How has Relay Therapeutics, Inc.'s other accrued liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s other accrued liabilities decreased by 49.6% year-over-year, from $1.68M to $847K.
- What is the long-term trend for Relay Therapeutics, Inc.'s other accrued liabilities?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s other accrued liabilities has grown at a 4.0% compound annual growth rate (CAGR), from $396K to $463K.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.